Benitec Biopharma's total assets for Q4 2025 were AU$99.59M, a decrease of -5.34% from the previous quarter. BNTC total liabilities were AU$2.30M for the fiscal quarter, a -69.93% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.